GON TECHNOLOGY (Qingdao Gon Technology Co., Ltd.) reported robust first-half 2026 results, driven by scale-up in petrochemical output and sustained demand across new materials and healthcare segments.
Revenue and Earnings • Operating revenue climbed 18.05% year on year to RMB11.51 billion. • Net profit attributable to shareholders jumped 89.33% to RMB654.81 million. • Net profit margin strengthened to 5.69%, versus 3.55% a year earlier. • Basic and diluted EPS rose 73.86% to RMB1.53.
Profitability • Gross profit advanced 54.88% to RMB1.53 billion; gross margin increased 3.16 percentage points to 13.28%. • Operating profit reached RMB774.24 million, up 101% from the prior-year period.
Segment Performance • New Chemical Materials contributed 90.46% of group revenue at RMB10.42 billion, up 21.07%. • Biomedical and Healthcare delivered RMB413.21 million, a 12.26% gain. • Revenue from Organic Polymer Modified Materials grew 11.57% to RMB5.48 billion, while Green Petrochemical Materials surged 47.14% to RMB2.89 billion.
Balance Sheet and Cash Flow • Total assets rose 14.17% to RMB22.59 billion; net assets attributable to shareholders increased 24.25% to RMB7.12 billion. • Gearing eased to 59.48% from 61.09% at end-2025. • Net operating cash flow slipped 5.14% to RMB320.64 million; free cash outflow reflected higher capex and investment spending.
Capital Markets and Dividend • The February 2026 Hong Kong listing raised net proceeds of HK$1.00 billion, earmarked mainly for Thailand and Yixing capacity expansions. • No interim dividend was declared.
R&D and Expenses • R&D outlays rose 32.81% year on year to RMB392.58 million, underscoring continued focus on technology innovation. • Administrative expenses increased 23.81% to RMB145.76 million, while finance costs were up 38.97% to RMB115.52 million, impacted by exchange losses.
Outlook Management reiterated its “One Core, Two Wings” strategy, aiming to deepen vertical integration in new chemical materials, accelerate expansion in upstream petrochemicals, and scale growth in life-science applications. The company also highlighted plans to invest in AI computing infrastructure and intelligent robotics to underpin future growth.